{
  "@context": "aku-v2",
  "@type": "clinical-concept",
  "@id": "vascular:carotid:cea-006-hyperperfusion-syndrome",
  "metadata": {
    "version": "1.0.0",
    "created": "2026-01-06T06:00:00.000Z",
    "last_updated": "2026-01-06T06:00:00.000Z",
    "contributors": ["copilot-agent", "knowledge-graph-agent"],
    "confidence": 0.95,
    "status": "validated",
    "copyright_compliance": "Original content based on general medical knowledge"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pathology/carotid",
    "type": "complication",
    "difficulty": "advanced",
    "importance": "critical",
    "aku_id": "CEA-006",
    "keywords": ["hyperperfusion syndrome", "reperfusion injury", "CEA complication", "intracerebral hemorrhage", "blood pressure control"],
    "medical_specialty": "vascular_surgery",
    "clinical_context": "cerebrovascular_disease",
    "board_yield": "HIGH"
  },
  "content": {
    "title": "Cerebral Hyperperfusion Syndrome After Carotid Intervention",
    "statement": {
      "text": "Cerebral hyperperfusion syndrome (CHS) is a rare but devastating complication of carotid revascularization characterized by unilateral headache, seizures, and potentially intracerebral hemorrhage due to sudden increase in cerebral blood flow to a chronically hypoperfused hemisphere.",
      "formal": "Incidence: 1-3% post-CEA/CAS; Triad: Ipsilateral headache, seizures, focal deficits; Risk: Severe stenosis, poor collaterals, hypertension; Prevention: Strict BP control"
    },
    "explanation": {
      "intuition": "After years of living with reduced blood flow, the brain's blood vessels lose their ability to constrict. When we suddenly restore full blood flow, these 'lazy' vessels can't tighten up, and too much blood floods into the brain tissue, causing swelling or bleeding.",
      "key_insight": "Strict blood pressure control post-CEA is the cornerstone of CHS prevention - even 'normal' pressures can be dangerously high for a hypoperfused brain.",
      "technical_details": "Cerebral hyperperfusion syndrome results from impaired cerebral autoregulation in chronically hypoperfused brain. After revascularization, cerebral blood flow can increase 2-3 fold. With defective autoregulation, small arterioles cannot constrict, leading to capillary leak, cerebral edema, and potentially hemorrhagic stroke. Risk factors include severe stenosis (>90%), contralateral occlusion, recent stroke, and perioperative hypertension. The classic triad is ipsilateral headache, seizures, and focal neurologic deficits. Treatment focuses on aggressive blood pressure control.",
      "common_misconceptions": [
        "CHS only occurs in the first 24 hours - FALSE, can occur up to 2 weeks post-op",
        "Normal blood pressure is safe post-CEA - FALSE, may need lower than usual BP targets",
        "CHS is just a headache - FALSE, can progress to fatal intracerebral hemorrhage",
        "Only CEA causes CHS - FALSE, also occurs after carotid stenting"
      ]
    },
    "pathophysiology": {
      "chronic_hypoperfusion": {
        "effect": "Loss of cerebral autoregulation",
        "mechanism": "Maximal vasodilation becomes chronic state",
        "result": "Inability to constrict when flow increases"
      },
      "post_revascularization": {
        "cbf_increase": "200-300% increase in cerebral blood flow",
        "capillary_damage": "Capillary leak, edema, microhemorrhage",
        "progression": "Edema â†’ hemorrhage if untreated"
      }
    },
    "risk_factors": {
      "anatomic": [
        "Severe stenosis (>90%)",
        "Contralateral carotid occlusion",
        "Poor circle of Willis collaterals"
      ],
      "clinical": [
        "Recent ipsilateral stroke",
        "Perioperative hypertension",
        "Diabetes mellitus",
        "Chronic hypertension"
      ],
      "procedural": [
        "Both CEA and CAS carry similar risk",
        "Staged bilateral procedures"
      ]
    },
    "clinical_presentation": {
      "timing": "Hours to 14 days post-procedure (peak days 3-7)",
      "classic_triad": [
        "Ipsilateral headache (throbbing, severe)",
        "Seizures (focal or generalized)",
        "Focal neurologic deficits"
      ],
      "progression": [
        "Mild: Headache only",
        "Moderate: Headache + seizure or confusion",
        "Severe: Intracerebral hemorrhage (ICH)"
      ]
    },
    "diagnosis": {
      "clinical": "High index of suspicion with headache post-CEA/CAS",
      "imaging": {
        "ct_head": "Rule out hemorrhage",
        "mri": "PRES-like findings (edema in watershed zones)",
        "tcd": "Increased MCA velocities (>100% baseline)"
      }
    },
    "prevention": {
      "perioperative_bp_control": {
        "target": "SBP <140 mmHg, or 20% below baseline",
        "duration": "At least 7-14 days post-procedure",
        "agents": ["Labetalol", "Nicardipine", "Clonidine"]
      },
      "monitoring": [
        "Frequent neurologic checks",
        "BP monitoring Q1-4h post-op",
        "TCD monitoring in high-risk patients"
      ],
      "patient_education": [
        "Report severe headache immediately",
        "Strict BP medication compliance",
        "Avoid straining, heavy lifting"
      ]
    },
    "treatment": {
      "mild_chs": {
        "bp_control": "Aggressive, target SBP <120 mmHg",
        "monitoring": "ICU level observation",
        "seizure_prophylaxis": "Consider in high-risk"
      },
      "seizures": {
        "agents": "Levetiracetam, phenytoin, or benzodiazepines",
        "duration": "At least until edema resolves"
      },
      "intracerebral_hemorrhage": {
        "bp_control": "Emergent lowering of BP",
        "neurosurgery": "Consult for hematoma evacuation if indicated",
        "prognosis": "High morbidity and mortality"
      }
    },
    "outcomes": {
      "incidence": "1-3% post-CEA/CAS",
      "ich_rate": "0.5-1% of all carotid interventions",
      "ich_mortality": "40-50%"
    },
    "terminology": {
      "snomed_ct": "433139008",
      "icd_10": "I67.4"
    }
  },
  "skos": {
    "prefLabel": {"@language": "en", "@value": "Cerebral Hyperperfusion Syndrome"},
    "altLabel": ["CHS", "Hyperperfusion Syndrome", "Reperfusion Syndrome After CEA"],
    "definition": {"@language": "en", "@value": "A complication of carotid revascularization characterized by excessive cerebral blood flow due to impaired autoregulation, manifesting as headache, seizures, and potentially intracerebral hemorrhage."},
    "notation": "CEA-006"
  },
  "clinical_features": {
    "presentation": [
      "Severe ipsilateral headache post-CEA/CAS",
      "Seizures (focal or generalized)",
      "Altered mental status",
      "Focal neurologic deficits"
    ],
    "diagnosis": [
      "Clinical suspicion with appropriate symptoms",
      "CT head to rule out hemorrhage",
      "TCD showing increased velocities"
    ],
    "treatment": [
      "Aggressive blood pressure control",
      "Seizure management",
      "ICU monitoring",
      "Neurosurgery consultation for ICH"
    ]
  },
  "relationships": {
    "prerequisites": ["vascular:carotid:cea", "vascular:carotid:cerebral-autoregulation"],
    "enables": ["vascular:carotid:complication-prevention"],
    "skos:broader": ["vascular:carotid:cea-complications"],
    "skos:related": ["vascular:carotid:carotid-stenting", "vascular:carotid:postoperative-care"],
    "skos:narrower": []
  },
  "provenance": {
    "sources": [
      {
        "type": "review_article",
        "reference": "Systematic reviews on CHS incidence and risk factors",
        "evidence_level": "IIa"
      },
      {
        "type": "clinical_guideline",
        "reference": "AHA/ASA Guidelines on Carotid Revascularization",
        "evidence_level": "B"
      }
    ]
  },
  "pedagogical": {
    "target_audience": ["vascular surgery residents", "neurosurgery residents", "neurology residents"],
    "estimated_time": "15min",
    "learning_objectives": [
      "Explain the pathophysiology of cerebral hyperperfusion syndrome",
      "Identify risk factors for CHS",
      "Recognize clinical presentation and implement appropriate workup",
      "Describe prevention and treatment strategies"
    ],
    "clinical_pearls": [
      "Post-CEA headache is a red flag - may herald hyperperfusion",
      "Strict BP control (SBP <140) for at least 1-2 weeks post-op",
      "CHS can occur up to 2 weeks after procedure",
      "Intracerebral hemorrhage from CHS has 40-50% mortality",
      "High-risk: >90% stenosis, contralateral occlusion, recent stroke"
    ],
    "board_yield": "HIGH"
  },
  "medicalCode": [
    {
      "@type": "MedicalCode",
      "codeValue": "433139008",
      "codingSystem": "SNOMED-CT",
      "name": "Cerebral hyperperfusion syndrome"
    },
    {
      "@type": "MedicalCode",
      "codeValue": "I67.4",
      "codingSystem": "ICD-10-CM",
      "name": "Hypertensive encephalopathy"
    },
    {
      "@type": "MedicalCode",
      "codeValue": "I61.9",
      "codingSystem": "ICD-10-CM",
      "name": "Nontraumatic intracerebral hemorrhage, unspecified"
    }
  ]
}
